alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 11

                        Computation of Earnings Per Share
                                   (Unaudited)


<TABLE>
<CAPTION>

                                           Three Months Ended                            Nine Months Ended
                                   ------------------------------------       -------------------------------------
                                   Dec. 31, 1996          Dec. 31, 1995       Dec. 31, 1996           Dec. 31, 1995
                                   -------------          -------------       -------------           -------------

<S>                                     <C>                  <C>                 <C>                       <C>      
Weighted average common                 7,562,500            5,290,000           7,150,416                 5,290,000
shares outstanding

Dilutive effect of common
equivalent shares (a)                      38,900               38,900              38,900                    38,900

Weighted average shares
   outstanding                          7,601,400            5,328,900           7,189,316                 5,328,900
                                  ================        =============        ============         =================

Net loss                          $   (2,046,936)         $                   $                         $ (1,675,878)
                                                           (1,508,910)         (5,199,487)
                                  ================        =============       =============            ==============

Fully diluted earnings per
share (b)                                $  (.27)              $ (.28)             $ (.72)                    $ (.31)
                                  ================        =============       =============     =====================

</TABLE>


(a)  Calculates the dilutive effect of outstanding  stock options based upon the
     "Treasury Stock Method".

(b)  As fully  diluted  earning  per share and  primary  earnings  per share are
     equal,  only fully diluted earnings per share will be disclosed in the Form
     10-QSB.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMTION EXTRACTED FROM
DUKE-WEEKS REALTY LIMITED PARTNERSHIP AND SUBSIDIARIES' CONDENSED
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          44,812
<SECURITIES>                                         0
<RECEIVABLES>                                   81,101
<ALLOWANCES>                                   (3,202)
<INVENTORY>                                          0
<CURRENT-ASSETS>                               172,895
<PP&E>                                       5,053,372
<DEPRECIATION>                               (234,071)
<TOTAL-ASSETS>                               5,336,192
<CURRENT-LIABILITIES>                          272,825
<BONDS>                                      1,964,857
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   3,097,902
<TOTAL-LIABILITY-AND-EQUITY>                 5,336,192
<SALES>                                              0
<TOTAL-REVENUES>                               415,194
<CGS>                                                0
<TOTAL-COSTS>                                (210,529)
<OTHER-EXPENSES>                              (33,949)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (59,080)
<INCOME-PRETAX>                                111,636
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            111,636
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   111,636
<EPS-BASIC>                                    $1.00
<EPS-DILUTED>                                    $1.00


</TABLE>
[Federal Register Volume 80, Number 23 (Wednesday, February 4, 2015)]
[Notices]
[Page 6094]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-02091]



[[Page 6094]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health and 
Human Development; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Child Health and Human Development Special Emphasis Panel, 
February 18, 2015, 12:00 p.m. to February 18, 2015, 5:00 p.m., Embassy 
Suites at the Chevy Chase Pavilion, 4300 Military Road, Washington, DC 
20015 which was published in the Federal Register on January 13, 2015, 
80 FR 8, page 1647.
    The meeting notice is amended to change the location to the Embassy 
Suites at the Chevy Chase Pavilion, 4300 Military Road, Washington, DC 
20015. The meeting is closed to the public.

    Dated: January 29, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-02091 Filed 2-3-15; 8:45 am]
BILLING CODE 4140-01-P
Exhibit 31.1

CERTIFICATION

I,
Mitch Lasky, Chief Executive Officer of JAMDAT Mobile Inc., certify that:

1.     I
have reviewed this Annual Report on Form 10-K for the year ended December 31, 2004;

2.     Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The
registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



5.     The
registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):



|Date: March 28, 2005 |  | By: | /s/MITCH LASKYMitch Lasky Chief Executive Officer
|-------------------- |  | --- | -------------------------------------------------

---



QuickLinks
<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED> 
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   11-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             FEB-01-1995
<PERIOD-END>                               DEC-31-1995
<EXCHANGE-RATE>                                      1
<CASH>                                         425,931
<SECURITIES>                                         0
<RECEIVABLES>                                  338,693
<ALLOWANCES>                                   (10,000)
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,533,053
<PP&E>                                         768,333
<DEPRECIATION>                                 191,826
<TOTAL-ASSETS>                               3,228,289
<CURRENT-LIABILITIES>                        3,796,391
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     1,671,190
<OTHER-SE>                                  (2,239,292)
<TOTAL-LIABILITY-AND-EQUITY>                  (568,102)
<SALES>                                              0
<TOTAL-REVENUES>                             5,023,711
<CGS>                                                0
<TOTAL-COSTS>                                1,622,669
<OTHER-EXPENSES>                             2,696,277
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (12,060)
<INCOME-PRETAX>                                810,268
<INCOME-TAX>                                   255,999
<INCOME-CONTINUING>                            554,269
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   554,269
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.18
        

</TABLE>
#### Steffke, Appellant, vs. Reinemann, Executor, and others, Respondents.

For the appellant: *Genrich & Genrich,*attorneys, and *Herbert L. Terwilliger*and *James A. Fitzpatrick*of counsel, all of Wausau.

For the respondents: *Bassuener, Humke & Poole*of Sheboygan and *Barnard & Mullen*of Oshkosh.

*By the Court.*

Judgment affirmed.
HomeNuclear SecurityRadioactive Material SecurityIntegrated Source Management Portfolio (ISMP)National Source Tracking System (NSTS)

# Contact Us About the National Source Tracking System

The U.S. Nuclear Regulatory Commission and the National Source Tracking System (NSTS) staff are interested in receiving your suggestions, comments, or questions. Please complete the form below. If you would prefer to be anonymous, simply omit the"Name" and "e-mail" fields. **Note, however, that if you choose to omit these fields, you will not receive a response**.

If you need to report a safety concern, please do not use this page. Instead, please see Report a Safety or Security Concern.

Would you like to remain anonymous?:*

YesNo

Privacy Policy

Privacy Policy

Page Last Reviewed/Updated Tuesday, December 7, 2021

Section Navigation

#### Navigation

          - NSTS Login
          - National Source Tracking System: Blog
          - NSTS Overview
          - Background
          - Get Credentialed to Access NSTS
          - How to Report to NSTS
          - Resources  for Online Reporting
          - NSTS Expansion
          - Annual Inventory Reconciliation
          - NSTS Presentations
          - Frequently Asked Questions
          - Help Desk Support
          - Contact Us

#### Spotlight

#### Choose a Section

                - The Commission
                - License Renewal Generic Environmental Review
                - Job Openings
                - Palisades Restart
                - Environmental Justice 
                - Pilgrim Water Releases
                - Monticello Tritium Issue
                - International Strategy 2021-2025
                - Tribal Liaison Program
                - MAP-X
                - Transformation at the NRC - Updated
                - OIG Hotline
                - Rulemaking Activity
                - Commission Documents
                - Advanced Reactors
                - Nuclear Security
                - Strategic Plan

Page Last Reviewed/Updated Tuesday, December 7, 2021
Exhibit 13.1
– Certification of CEO and CFO



CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers
of Medicure Inc. (the “Company”), does hereby certify with respect to the Annual Report of the Company on Form 20-F
for the year ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the “Form
20-F”), that, to the best of his knowledge:



(1) the Form 20-F fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) the information contained in the Form
20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.



|Date:  April 26, 2017 | /s/ Albert Friesen                              
|--------------------- | ------------------------------------------------
|                      | Albert D. Friesen Ph D., Chief Executive Officer
|                      | (Principal Executive Officer)                   
|                      |                                                 
|Date:  April 26, 2017 | /s/ James Kinley                                
|                      | James F. Kinley CA, Chief Financial Officer     
|                      | (Principal Financial Officer)                   



A signed original of this written statement
required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in
typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
#### Frayer and another, Appellants, vs. Industrial Commission and another, Respondents.

For the appellants: *Quarles, Spence & Quarles,*attorneys, and *Arthur B. Doe*of counsel, all of Milwaukee.

For the respondent Industrial Commission: *James E. Finnegan,*attorney general, and *Mortimer Levitan,*assistant attorney general.

*By the Court.*

Judgment affirmed.
*March 6, 1934.*

#### Estate of Lehner: Lehner, Claimant, Appellant, vs. Kohl, Administrator, and another, Respondents.

For the appellant: *Gooding & Gooding*of Fond du Lac.

For the respondents : *George C. Wheeler*of Mayville and *George A. Hartman*of Juneau.

*John A. Thiel*of Mayville, attorney for the widow, Anna Lehner.

*By the Court.*

Judgment affirmed.
EXHIBIT 31.1
 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this Quarterly Report on Form 10-Q for the fiscal
quarter ended June 30, 2009 of Impax Laboratories, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:
 (a)
    
    Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be
designed under our supervision, to ensure that
material information relating to the registrant,
including its consolidated subsidiaries, is made known
to us by others within those entities, particularly
during the period in which this report is being
prepared;(b)
    
    [Intentionally omitted];(c)
    
    Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in
this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end
of the period covered by this report based on such
evaluation; and(d)
    
    Disclosed in this report any change in the
registrants internal control over financial reporting
that occurred during the registrants most recent
fiscal quarter (the registrants fourth fiscal quarter
in the case of an annual report) that has materially
affected, or is reasonably likely to materially
affect, the registrants internal control over
financial reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based
on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the
registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrants
ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrants
internal control over financial reporting.
 August 5, 2009
    By:
    /s/ Larry Hsu, Ph.D.Larry Hsu, Ph.D.President and Chief Executive Officer
# C_2004234EN.01000202.xml

| 21.9.2004 | EN | Official Journal of the European Union | C 234/2 |
| --- | --- | --- | --- |

21.9.2004

EN

Official Journal of the European Union

C 234/2

---

Non-opposition to a notified concentration

(Case No COMP/M.3538 — UNIQUA/CLARIS VITA)

(2004/C 234/03)

(Text with EEA relevance)

On 13 September 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in Italian and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/) free of charge. This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form in the ‘CIT’ version of the CELEX database, under document number 32004M3538. CELEX is the computerized documentation system of European Community law. (http://europa.eu.int/celex) |
| --- | --- |

—

in electronic form in the ‘CIT’ version of the CELEX database, under document number 32004M3538. CELEX is the computerized documentation system of European Community law. (http://europa.eu.int/celex)

---
HomeNuclear SecurityRadioactive Material SecurityIntegrated Source Management Portfolio (ISMP)National Source Tracking System (NSTS)

# National Source Tracking System: Blog

subscribe to page updates

**Blog Archives:** | 2024 | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |

January 19, 2024

## **ADVANCE NOTIFICATION OF FEE CHANGE REGARDING SUBMITTAL OF FINGERPRINT CARDS**

Effective February 1, 2024, the fee for processing fingerprint cards will be decreased to $32.00 per file. The current fee of $35.00 per file remains in effect through January 31, 2024.

Public notification detailing the decrease in the fee is provided in a *Federal Register*notice issued on January 10, 2024 (89 FR 1602).

An update regarding this upcoming change may also be found on the NRC public Web site at Licensee Criminal History Records Checks & Firearms Background Check Information and 10 CFR Part 37.

Page Last Reviewed/Updated Friday, January 19, 2024

Section Navigation

#### Navigation

          - NSTS Login
          - National Source Tracking System: Blog
          - NSTS Overview
          - Background
          - Get Credentialed to Access NSTS
          - How to Report to NSTS
          - Resources  for Online Reporting
          - NSTS Expansion
          - Annual Inventory Reconciliation
          - NSTS Presentations
          - Frequently Asked Questions
          - Help Desk Support
          - Contact Us

#### Spotlight

#### Choose a Section

                - The Commission
                - License Renewal Generic Environmental Review
                - Job Openings
                - Palisades Restart
                - Environmental Justice 
                - Pilgrim Water Releases
                - Monticello Tritium Issue
                - International Strategy 2021-2025
                - Tribal Liaison Program
                - MAP-X
                - Transformation at the NRC - Updated
                - OIG Hotline
                - Rulemaking Activity
                - Commission Documents
                - Advanced Reactors
                - Nuclear Security
                - Strategic Plan

#### Search NSTS Blog

Page Last Reviewed/Updated Friday, January 19, 2024
# C_2004118EN.01002402.xml

| 30.4.2004 | EN | Official Journal of the European Union | C 118/24 |
| --- | --- | --- | --- |

30.4.2004

EN

Official Journal of the European Union

C 118/24

---

JUDGMENT OF THE COURT

JUDGMENT OF THE COURT

(Sixth Chamber)

of 29 April 2004

in Case C-371/02 (reference for a preliminary ruling from the Svea hovrätt): Björnekulla Fruktindustrier AB v Procordia Food AB (1)

1

(Trade marks - Directive 89/104/EEC - Article 12(2)(a) - Revocation of rights conferred by the trade mark - Trade mark which has become the common name in the trade - Relevant classes of persons for purposes of the assessment)

(2004/C 118/42)

Language of the case: Swedish

In Case C-371/02: reference to the Court under Article 234 EC from the Svea hovrätt (Svea Court of Appeal) (Sweden) for a preliminary ruling in the proceedings pending before that court between Björnekulla Fruktindustrier AB and Procordia Food AB — on the interpretation of Article 12(2)(a) of First Council Directive 89/104/EEC of 21 December 1988 to approximate the laws of the Member States relating to trade marks (OJ 1989 L 40, p. 1), — the Court (Sixth Chamber) composed of: V. Skouris, acting as the President of the Sixth Chamber, C. Gulmann (Rapporteur), J.N. Cunha Rodrigues, J.-P. Puissochet and R. Schintgen, Judges; P. Léger, Advocate General; H. von Holstein, Deputy Registrar, for the Registrar, has given a judgment on 29 April 2004, in which it has ruled:

Article 12(2)(a) of First Council Directive 89/104/EEC of 21 December 1988 to approximate the laws of the Member States relating to trade marks must be interpreted as meaning that in cases where intermediaries participate in the distribution to the consumer or the end user of a product which is the subject of a registered trade mark, the relevant classes of persons whose views fall to be taken into account in determining whether that trade mark has become the common name in the trade for the product in question comprise all consumers and end users and, depending on the features of the market concerned, all those in the trade who deal with that product commercially.

---

(1)  OJ C 305, 7.12.2002.

1

---